COMMUNIQUÉS West-GlobeNewswire

Akcea Therapeutics to Hold First Quarter 2019 Financial Results Webcast
24/04/2019
Webcast scheduled for Wednesday, May 8th at 4:30 p.m. Eastern Time BOSTON, April 24, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that it [...]
BioVie to Present at ThinkEquity Conference in NYC on May 2nd
24/04/2019
LOS ANGELES, April 24, 2019 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, announced that Mr. Terren Peizer, the [...]
Aclaris Therapeutics Announces Issuance of a Patent Covering the use of Ruxolitinib and its Deuterated Forms to Treat Alopecia Areata
24/04/2019
WAYNE, Pa., April 24, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced that the [...]
Surface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day
24/04/2019
CAMBRIDGE, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Kane Biotech Announces New Sales Representation by SLA Brands
24/04/2019
WINNIPEG, Manitoba, April 24, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Sharps Compliance Reports Fiscal 2019 Third Quarter Results
24/04/2019
Third quarter 2019 revenue was $9.5 million, a slight increase over the prior year revenue Net loss of $1.1 million and net loss per share of $0.07 for the quarter Route-based business increased 20% MedSafe collection [...]
Precision BioSciences Announces Presentations at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy
24/04/2019
DURHAM, N.C., April 24, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS ® genome editing platform, [...]
ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies
24/04/2019
Distribution agreement for Tru Niagen (nicotinamide riboside) in Vancouver area provides access to high-end pharmacies and clinics LOS ANGELES, April 24, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced [...]
Integra LifeSciences Reports First Quarter 2019 Financial Results
24/04/2019
Reported revenues amounted to $359.7 million; organic revenues increased 3.1% GAAP and adjusted earnings per diluted share were $0.38 and $0.65, respectively The Company reaffirms reported and organic revenue guidance [...]
Amarin To Report First Quarter 2019 Results and Host Conference Call On May 1, 2019
24/04/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, April 24, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that it will host a [...]
Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board
24/04/2019
Press release, Helsinki, 24 April 2019 at 9.30 am (EET) Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and [...]
CellaVision AB presents the first quarter for 2019 on May 7 at 11:00 CET
24/04/2019
The information was submitted to the public on April 24, 2018 at 8:20 CET CellaVision AB (publ) will publish the interim report for the first quarter on May 7, 2019 at 8:20 CET. The report will be available at www. [...]
Interim report for the first 3 months of 2019
24/04/2019
Please read the full announcement in the attached PDF Attachment 2019_07_Q12019_CompanyAnnouncement_EN_FINAL
Oxurion NV announces full enrollment in its Phase 1 trial evaluating the safety of its plasma kallikrein inhibitor THR-149 for treatment of DME, ahead of schedule
24/04/2019
Leuven, Belgium, 24 April 2019 - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diabetic eye disease, announces today that it has [...]
Novartis starts 2019 with strong sales and double digit core[1] operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded
24/04/2019
Transformation to focused medicines company continued with the spin-off of Alcon; commentary below is on continuing operations[2] Continuing operations net sales up 7% (cc[1], +2% USD) driven by Innovative Medicines: [...]
Novartis entame 2019 avec une forte croissance des ventes et une hausse à deux chiffres du résultat opérationnel core[1], le lancement de Mayzent et le spin-off d'Alcon; profit annuel revu à la hausse
24/04/2019
La transformation en une société axée sur les médicaments a continué avec le spin-off d'Alcon; les commentaires ci-après ne concernent que les activités poursuivies[2] Chiffre d'affaires net des activités poursuivies en [...]
MDxHealth (R): MDxHealth provides Q1 2019 business update
24/04/2019
NEWS RELEASE REGULATED INFORMATION IRVINE, CA, and HERSTAL, BELGIUM - April 24, 2019 - MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today provided a business update for [...]
MDxHealth (R) : MDxHealth publie son rapport d'activité du T1 2019
24/04/2019
COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES IRVINE, CA, et HERSTAL, Belgique - le 24 avril 2019 - MDxHealth SA (Euronext : MDXH.BR), une société spécialisée dans le diagnostic moléculaire à un stade commercial, a [...]
Number of shares and voting rights of Innate Pharma as at April 18, 2019
24/04/2019
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS AT APRIL 18, 2019 Marseille, France, April 24, 2018, 7:00 AM CET Pursuant to the article L. 233-8 II of the French « Code de Commerce » and the article 223-16 of [...]

Pages